These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5788082)

  • 41. [Contemporary problems in the development of goal-oriented pharmacotherapy].
    Modr Z
    Zdrav Aktual; 1979; 191():20-8. PubMed ID: 550640
    [No Abstract]   [Full Text] [Related]  

  • 42. Extra-label drug use--veterinary practitioner views: companion animals.
    Cleland JL
    J Am Vet Med Assoc; 1993 May; 202(10):1642-4;discussion 1654-58. PubMed ID: 8514572
    [No Abstract]   [Full Text] [Related]  

  • 43. Where does drug importation stand now?
    Guglielmo WJ
    Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085
    [No Abstract]   [Full Text] [Related]  

  • 44. Policy must recognize drug impact on different sectors.
    Pierce R; Illes J
    Nature; 2008 Jan; 451(7178):521. PubMed ID: 18235479
    [No Abstract]   [Full Text] [Related]  

  • 45. Global health and university patents.
    Kapczynski A; Crone ET; Merson M
    Science; 2003 Sep; 301(5640):1629. PubMed ID: 14500943
    [No Abstract]   [Full Text] [Related]  

  • 46. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
    Curti AM
    Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
    [No Abstract]   [Full Text] [Related]  

  • 47. The World Health Organization's prequalification program and its potential effect on data exclusivity laws.
    Childs DW
    Food Drug Law J; 2005; 60(1):79-97. PubMed ID: 15940855
    [No Abstract]   [Full Text] [Related]  

  • 48. Perspectives. Internet likely to open brave new world in global pharmaceuticals trade.
    Otrompke J
    Med Health; 2000 Oct; 54(39):suppl 1-4. PubMed ID: 11184825
    [No Abstract]   [Full Text] [Related]  

  • 49. Preventing the accumulation of surplus controlled substances at long term care facilities. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 May; 70(92):25462-6. PubMed ID: 15892213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Medicaid program; multiple source drug definition. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Oct; 73(195):58491-7. PubMed ID: 18985965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Drug preparations from the Czechoslovak pharmaceutical industry].
    Tiurin VG
    Voen Med Zh; 1976 Apr; (4):92-3. PubMed ID: 1274255
    [No Abstract]   [Full Text] [Related]  

  • 52. Regulating the fate of pharmaceutical drugs: a new prescription for the environment.
    Nidel CT
    Food Drug Law J; 2003; 58(1):81-101. PubMed ID: 12739585
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug donations must be strictly regulated. Georgia has tight guidelines.
    Schouten E
    BMJ; 1995 Sep; 311(7006):684. PubMed ID: 7549644
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prices of pharmaceutical preparations in Denmark until 1645: a study of the legislation for stipulating the consumer price of drugs].
    Kruse PR
    Theriaca; 1991 Oct; 27():3-315. PubMed ID: 11640853
    [No Abstract]   [Full Text] [Related]  

  • 55. New drugs.
    Hussar DA
    Nursing; 1982 May; 12(5):33-40. PubMed ID: 6918836
    [No Abstract]   [Full Text] [Related]  

  • 56. Distribution of certain drug products by registered blood establishments and comprehensive hemophilia diagnostic treatment centers that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements and administrative procedures. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Oct; 73(197):59496-501. PubMed ID: 18985968
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?
    Toop L; Richards D; Saunders B
    N Z Med J; 2003 Aug; 116(1180):U556; discussion U556. PubMed ID: 14581976
    [No Abstract]   [Full Text] [Related]  

  • 58. [New original preparations developed at the VUFB in Prague].
    Krepelka J
    Cesk Farm; 1985 Feb; 34(1):17-22. PubMed ID: 3986932
    [No Abstract]   [Full Text] [Related]  

  • 59. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 60. Informed consent--a new approach to drug regulation?
    Nutt DJ
    J Psychopharmacol; 2006 Jan; 20(1):3-4. PubMed ID: 16354734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.